SciTech Development is a clinical-stage oncology pharmaceutical company that provides cancer treatment services. It offers ST-001 nanoFenretinide, a formulation in clinical trials for T-cell lymphomas, and a nanoparticle drug delivery platform (SDP) that maximizes the bioavailability of water-insoluble therapeutics and develops drugs for cancer treatment.